Location History:
- Madrid, ES (2007)
- Alcobendas, ES (2010)
Company Filing History:
Years Active: 2007-2010
Title: Howard Barff Broughton: Innovator in Pharmaceutical Research
Introduction
Howard Barff Broughton is a notable inventor based in Alcobendas, Spain. He has made significant contributions to the field of pharmaceutical research, holding two patents that focus on therapeutic compounds with potential applications in treating various diseases.
Latest Patents
Broughton's recent patents include innovative compositions such as "3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives" specifically designed as BACE inhibitors. This invention outlines methods for their use and preparation, in addition to detailing intermediates useful for their production. Another key patent involves "Opioid receptor antagonists," which presents a compound formula beneficial for the treatment, prevention, or alleviation of obesity and related diseases. The compound includes variables defined in the patent specifications, as well as variations like salts and enantiomers to increase its applicability.
Career Highlights
Howard Barff Broughton is currently employed at Eli Lilly and Company, a global leader in pharmaceuticals. His work focuses on innovative drug development, aiming to create effective treatment options for complex health issues. His expertise in medicinal chemistry has allowed him to be at the forefront of drug discovery.
Collaborations
Broughton collaborates with esteemed colleagues, including Robert Dean Dally and Timothy Barrett Durham. Their combined expertise fosters a collaborative environment conducive to groundbreaking research and development in pharmaceuticals.
Conclusion
Howard Barff Broughton exemplifies the spirit of innovation in the realm of pharmaceutical research. Through his patents and collaborations, he continues to contribute valuable solutions to the healthcare industry, addressing critical health challenges faced by society today.